New research links noninvasive brain blood flow and oxygenation markers to hallmark Alzheimer's disease changes, suggesting early risk detection potential.
Key Details
- 1Study conducted at the Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC.
- 2Researchers used transcranial Doppler ultrasound and near-infrared spectroscopy to measure brain blood flow and oxygenation.
- 3Findings associated higher vascular function indicators with lower amyloid plaques and larger hippocampal volume.
- 4Amyloid PET imaging was also used to correlate vascular markers with known AD pathology.
- 5Techniques are less costly and more tolerable for large-scale or difficult-to-image populations than MRI or PET.
- 6Longitudinal studies are underway to assess if changes in these markers can predict cognitive decline.
Why It Matters
Demonstrating a link between vascular brain health (measured noninvasively) and established Alzheimer’s imaging findings could enable earlier and easier risk stratification. The use of noninvasive, accessible tools may facilitate broad screening and intervention research in populations unable to tolerate extensive imaging.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.